Attendees who purchased access to the 2016 Annual Meeting webcast were sent login information on May 11, 2016.

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

  • Sort by:
  • Browse by:
<< first | < prev page: of 4 records per page: next > | last >>
pages: 1 2 3 4 presentations: 1 to 25 of 79
Molecular Pharmacology of Hormone-dependent Malignancies
ESR1 coregulator binding inhibitor (ECBI): a novel agent for treating hormone therapy-resistant breast cancer
Ratna K. Vadlamudi
UT Health Science Center at San Antonio, San Antonio, TX, United States
from AACR Annual Meeting 2016 on April 17, 2016 4:15 PM-6:15 PM
Molecular Pharmacology of Hormone-dependent Malignancies
Global transcription factor repression by the coactivator SRC-1 mediates disease progression in endocrine-resistant breast cancer
Damir Vareslija
Royal College of Surgeons in Ireland, Dublin, Ireland
from AACR Annual Meeting 2016 on April 17, 2016 4:15 PM-6:15 PM
Molecular Pharmacology of Hormone-dependent Malignancies
WNT4 mediates endocrine response and resistance in invasive lobular carcinoma cell lines and patient tumor explants
Matthew J Sikora
University of Pittsburgh, Pittsburgh, PA, United States
from AACR Annual Meeting 2016 on April 17, 2016 4:15 PM-6:15 PM
Molecular Pharmacology of Hormone-dependent Malignancies
Differential activity and SERD sensitivity of clinical ESR1 mutations
Weiyi Toy
Memorial Sloan-Kettering Cancer Center, New York, NY, United States
from AACR Annual Meeting 2016 on April 17, 2016 4:15 PM-6:15 PM
Molecular Pharmacology of Hormone-dependent Malignancies
Androgen receptor stability in prostate cancer is regulated by the cochaperone Bag-1L
Laura Cato
Dana-Farber Cancer Institute and the Center for Functional Cancer Epigenetics, Boston, MA, United States
from AACR Annual Meeting 2016 on April 17, 2016 4:15 PM-6:15 PM
Molecular Pharmacology of Hormone-dependent Malignancies
Isolation of WDR77-mediated interaction between androgen receptor and p53 uncovers novel treatment strategy for prostate cancer
Sangeeta Kumari
Cleveland Clinic, Cleveland, OH, United States
from AACR Annual Meeting 2016 on April 17, 2016 4:15 PM-6:15 PM
Molecular Pharmacology of Hormone-dependent Malignancies
Delineation of novel CYP24A1 transcriptional regulators
Wei Luo
Roswell Park Cancer Institute, Buffalo, NY, United States
from AACR Annual Meeting 2016 on April 17, 2016 4:15 PM-6:15 PM
Unraveling Hormone Dependence in Cancer
Invited Speaker
Myles A. Brown
Dana-Farber Cancer Institute, Boston, MA, United States
from AACR Annual Meeting 2015 on April 19, 2015 7:00 AM-8:00 AM
New Insights in Estrogen Receptor Biology and Implications for Treatment
Understanding the genomic properties of estrogen receptor activity in breast cancer
Jason Carroll
Cancer Research UK Cambridge Research Inst., Cambridge, United Kingdom
from AACR Annual Meeting 2015 on April 19, 2015 1:00 PM-3:00 PM
New Insights in Estrogen Receptor Biology and Implications for Treatment
Biologic and clinical significance of estrogen receptor mutations in cancer
Sarat Chandarlapaty
Memorial Sloan Kettering Cancer Center, New York, NY, United States
from AACR Annual Meeting 2015 on April 19, 2015 1:00 PM-3:00 PM
New Insights in Estrogen Receptor Biology and Implications for Treatment
Mechanisms and therapy potential for transcriptional coactivators
David M. Lonard
Baylor College of Medicine, Houston, TX, United States
from AACR Annual Meeting 2015 on April 19, 2015 1:00 PM-3:00 PM
New Insights in Estrogen Receptor Biology and Implications for Treatment
PET Imaging of Breast Cancers to Predict Patient Benefit from Endocrine Therapies
John A. Katzenellenbogen
University of Illinois at Urbana-Champaign, Urbana, IL, United States
from AACR Annual Meeting 2015 on April 19, 2015 1:00 PM-3:00 PM
Molecular Endocrinology of Breast and Prostate Cancer
Parity and short-term estradiol treatment confers protection against breast cancer by suppressing cell survival and migration
Arunkumar Arumugam
Texas Tech University Health Sciences Center, El Paso, TX, United States
from AACR Annual Meeting 2015 on April 21, 2015 3:00 PM-5:00 PM
Molecular Endocrinology of Breast and Prostate Cancer
Localization of estrogen receptor α(ERα) at the centrosome and its regulation by protein kinases in breast cancer cells
Yingfeng Zheng
University of Manitoba, Winniepg, MB, Canada
from AACR Annual Meeting 2015 on April 21, 2015 3:00 PM-5:00 PM
Molecular Endocrinology of Breast and Prostate Cancer
GR activation modifies ER transcriptional activity and results in decreased estrogen-mediated breast cancer cell proliferation
Diana C West
Univ. of Chicago, Chicago, IL, United States
from AACR Annual Meeting 2015 on April 21, 2015 3:00 PM-5:00 PM
Molecular Endocrinology of Breast and Prostate Cancer
In silico and in vitro analyses of androgen receptor splicing variants with a special focus on human patient samples
Takuma Uo
Univ. of Washington, Seattle, WA, United States
from AACR Annual Meeting 2015 on April 21, 2015 3:00 PM-5:00 PM
Molecular Endocrinology of Breast and Prostate Cancer
Control of androgen receptor function by the genomic action of the cochaperone Bag-1L
Laura Cato
Dana-Farber Cancer Institute, Boston, MA, United States
from AACR Annual Meeting 2015 on April 21, 2015 3:00 PM-5:00 PM
Molecular Endocrinology of Breast and Prostate Cancer
A novel nuclear transporter for androgen receptor and AR-variant-7 in castration resistant prostate cancer: Ideal therapeutic target
Mohammad Saleem
University of Minnesota Hormel Institute, Austin, MN, United States
from AACR Annual Meeting 2015 on April 21, 2015 3:00 PM-5:00 PM
Molecular Endocrinology of Breast and Prostate Cancer
Silencing of PMEPA1, a NEDD4 E3 ubiquitin ligase binding protein, stabilizes androgen receptor and confers resistance to AR inhibitors
Hua Li
Uniformed Services University, CPDR, Rockville, MD, United States
from AACR Annual Meeting 2015 on April 21, 2015 3:00 PM-5:00 PM
PI3K-mTOR/PTEN
Regulation of metabolism by the PI3K pathway
Lewis C. Cantley
Weill Cornell Medical College of Cornell Univ., New York, NY, United States
from AACR Annual Meeting 2014 on April 5, 2014 8:00 AM-10:00 AM
PI3K-mTOR/PTEN
Preclinical validation: Target discovery in PI3K pathway using mouse models
Bart Vanhaesebroeck
UCL Cancer Institute, London, United Kingdom
from AACR Annual Meeting 2014 on April 5, 2014 8:00 AM-10:00 AM
PI3K-mTOR/PTEN
mTOR complex 1: Signal integrator and regulator of metabolism and growth in cancer
John Blenis
Harvard Medical School, Boston, MA, United States
from AACR Annual Meeting 2014 on April 5, 2014 8:00 AM-10:00 AM
PI3K-mTOR/PTEN
PTEN tumor suppressor regulation and dysfunction in cancer
Ramon E. Parsons
Icahn School of Medicine at Mount Sinai, New York, NY, United States
from AACR Annual Meeting 2014 on April 5, 2014 8:00 AM-10:00 AM
The LKB1 - AMPK Tumor Suppressor Pathway: Metabolic Reprogramming and Therapeutic Targeting
Invited Speaker
Reuben J. Shaw
Salk Institute, La Jolla, CA, United States
from AACR Annual Meeting 2014 on April 6, 2014 7:00 AM-8:00 AM
Targeting the Genetic and Metabolic Basis of Cancer
Invited Speaker
W. Marston Linehan
National Cancer Inst., Bethesda, MD, United States
from AACR Annual Meeting 2014 on April 7, 2014 7:00 AM-8:00 AM
<< first | < prev page: of 4 records per page: next > | last >>
pages: 1 2 3 4 presentations: 1 to 25 of 79